This patent application relates to medical devices using needles such as spinal needles, intravenous catheter introducers, blood collection devices and syringes. It includes methods of manufacturing needle based devices and needle shields for such devices.
The invention includes a method of making a needle assembly. The needle has a proximal end, a sharp distal end and a longitudinal axis. A needle shield assembly is provided with a blocking object carrier, a blocking object (preferably a ball) and a lumen coaxial with the longitudinal axis of the needle. The lumen has a proximal end and a distal end. The blocking object is moveable from a shielding position in which the blocking object at least partially occludes the lumen and a non-shielding position in which the needle can slide along the lumen. The blocking object is placed in the blocking object carrier in the shielding position. The proximal end of the needle is inserted into the distal end of the lumen and the needle shield assembly is moved such that the needle moves the blocking object from the shielding position to a non-shielding position.
A spring is attached to the blocking object carrier such that the spring biases the blocking object towards the longitudinal axis of the needle. If the device is a catheter introducer assembly then a catheter tube is threaded over the needle. A catheter adapter is snapped onto the needle shield assembly. At least part of the needle shield assembly is placed inside a catheter adapter. The blocking object is preferably a ball, but may be a non-spherical object such as a roller.
The blocking object carrier preferably holds the blocking object in a position offset from the longitudinal axis of the needle in the shielding position. At least part of the needle shield assembly is placed inside a catheter adapter.
A method of manufacturing a catheter introducer assembly is also disclosed. A polymeric tube is extruded and attached to a needle hub such that it slides relative to the needle hub. A catheter assembly is placed on the needle. In a further method of the invention, a second polymeric tube is extruded and secured to the needle hub. The first and second polymeric tubes are concentric. The step of extruding the polymeric tube may include providing reinforcing in the polymeric tube. The polymeric tube and the reinforcing may be coextruded.
Another method involves extruding a polymeric tube, securing a needle hub and a needle to the distal end of the polymeric tube and placing a catheter assembly on the needle. The polymeric tube may have a second, substantially parallel polymeric tube such that the polymeric tube comprises more than one lumen.
These and other features of the invention are described in greater detail below.
The following is a description of embodiments of the invention as applied to catheter introducers, a syringes and other needle based devices. It is not intended to limit the scope of the invention.
The invention may be applied to a wide variety of needle based devices such as catheter introducers, syringes, winged needles and Huber needles. In almost all cases, shielding a needle involves providing a needle shield and ensuring that it does not come off the sharp distal end of the needle or move proximally, thereby re-exposing the sharp distal end. Some sort of locking mechanism or mechanisms must therefore prevent distal and proximal movement of the shield once the needle is shielded.
In the present invention, proximal movement of the shield is prevented by the assembly shown in
In the non-shielding position shown in
As shield assembly 90 slides along needle 10, it approaches distal end 15. The biasing force in spring 2 forces ball 3 at least partially into lumen 93 and it leaves hole 21 and moves radially towards axis 11 in opening 18, as the bevel of needle 10 passes ball 3. Due to the geometry of opening 18, when the bevel has passed by, ball 3 lies at least partially in lumen 93.
Axis 24 of ball 3 lies offset from axis 11. Radial movement of ball 3 is restricted by spring 2 and by top wall 20 of cap 100. Axial movement of the ball is also restricted by front wall 22 of opening 18. Distal movement of needle 10 forces ball 3 against wall 22. If shield 90 now slides proximally (i.e. needle 10 slides distally), needle 10 will be blocked by ball 3, which lies at least partially in lumen 15 and movement of which is limited by spring 2 and walls 20 and 22.
Referring to
The above operation is described in greater detail and with slight variations in the remainder of this specification in the context of catheter introducers, syringes and other needle-based medical devices. Three types of catheter introducer are shown. In the first, distal movement of the needle shield off the sharp end of the needle is restrained by means of an abutment between the needle shield and a discontinuity on the introducer needle. In the second, the needle shield is on the end of a tubular member, distal movement of which is restrained by an abutment with a member attached to the needle hub. In the third, the needle shield is tethered to the needle hub, thereby preventing distal movement of the needle shield off the sharp end of the needle. The same applies to the syringe. In all cases, proximal movement and hence pulling back of the needle to expose the sharp end of the needle, is prevented by the device described above.
The following is a description of the invention as applied to a first type of catheter introducer assembly in which distal movement of the needle shield assembly is restrained by a discontinuity on the needle such as a bump or crimp. Reference is made to
The purpose of catheter introducer assembly 5 is to pierce a human or animal body with a needle, make an opening, insert a catheter tube into it and then remove the needle. In order to prevent the spread of infectious disease through needle sticks, the tip of the needle should be shielded once it is removed.
The body is pierced by needle 10, which has an outer surface 12, a proximal end 15, a distal end 20 and a lumen 22. Distal end 20 has a sharp tip or point 25. Distal end is beveled. In the drawings it is shown with two bevels—surfaces 30 and 40 forming a slope extending from the sharp point 25 in a proximal direction. More or less than two bevels may be used. Proximal end 15 is secured to needle hub 45. Needle 10 has an area of enlarged cross section 14 located close to distal end 20. This enlarged cross section can be in the form of an annular ring, enlarging the diameter of needle 10, a segmented ring or a discontinuity, bump or crimp on the needle. The enlarged cross section can be formed on needle 10 by crimping, grinding, deforming or depositing material on the surface of the needle. The difference between the diameter of needle 10 and this enlarged cross section is very small—about 0.004 inches—and its length is only about 0.03 inches.
Catheter assembly 50 has a catheter hub 52 having proximal end 55, distal end 60 and lumen 70 extending between the proximal and distal ends. Catheter tube 65 extends distally out of distal end 60. Needle 10 lies within lumen 70 of catheter assembly 50 prior to insertion into the body. Once needle 10 has been inserted into the patient, together with catheter tube 65, needle 10 is withdrawn by pulling it in a proximal direction. Catheter hub 52 has an inner surface 80 and an outer surface 82. Inner surface 80 is provided with a circumferential groove 75, the purpose of which will be explained in due course. A single depression, indentation, circumferential ridge or raised portion will serve the same purpose as the circumferential groove.
Needle shield assembly 90 is contained in two mating parts—first housing 95 and second housing or cap 100. Needle assembly housing 90 can fit within catheter hub 50. First housing 95 has a distal end 97 and a proximal end 99. Extending between the proximal and distal ends is lumen 93, which is dimensioned so that first housing 95 can slide axially and rotate on needle 10. Extending from near distal end 97 towards proximal end 99 is stepped area 105. This is an area of reduced diameter which allows coil spring 110 to be placed on first housing 95. Spring 110 is a compression spring, which exerts a force axially in the proximal and distal directions. Other types of springs can be used, for example, a leaf spring (see
Towards distal end 97 of first housing 95, but still in the stepped area 105, first housing 95 is provided with an opening 120, dimensioned to accommodate ball 122. Second housing or cap 100 has a proximal end 130 and a distal end 135. Proximal end 130 is provided with opening 140 which is dimensioned such that it is slightly larger than the diameter of needle 10, but slightly smaller than the diameter of area of enlarged cross section 14. Thus, second housing can slide axially along the needle from proximal end 15 towards distal end 20, until its opening 140 abuts area of enlarged cross section 14, at which time it cannot slide further in the distal direction. When first and second housings 95 and 100 are assembled, second housing 100 covers most of first housing 95, except for distal end 97 of the first housing. Second housing 100 thus covers spring 110. Second housing 100 is provided with opening 150 which is dimensioned such that part of ball 122 can protrude through it and into groove 75.
When needle shield assembly 90 is in catheter hub 52, prior to deployment, part of ball 122 protrudes through opening 150 and lies in groove 75. This locks needle shield assembly 90 to catheter hub 52, while allowing catheter hub 52 to rotate relative to needle shield assembly 90, depending on the extent of groove 75 (i.e. whether it is circumferential or permits only limited movement because it does not extend around the entire inner circumference of the catheter hub). Part of ball 122 also lies in lumen 93 of first housing 95 and abuts outer surface 12 of needle 10 (i.e. ball 122 touches outer wall 12 of needle 10). Needle 10 and shield assembly 90 can slide and rotate relative to each other with very low friction. Ball 122 is radially constrained by groove 75 and needle 10. Needle shield assembly 90 is thus locked into catheter hub 52. Spring 110 exerts a force on ball 122 axially, in the distal direction. Moreover, the presence of needle 10 abutting ball 122 radially constrains ball 122 and prevents it from moving out of groove 75.
Once catheter tube 65 has been placed in the patient, needle 10 is pulled in a proximal direction (that is to say, as needle shield assembly 90 moves towards tip 25 of needle 10). If first bevels 30 and 40 are facing ball 122, then, when first bevel 40 comes into alignment with ball 122, ball 122 is less radially constrained by needle 10 and, urged by spring 110, it begins to move in opening 120, distally and radially. Ball 122 thus moves out of opening 150 and groove 75 and radially inwards further into lumen 93 of shield assembly 90, pivoting about edge 155, (a wall of opening 150 in second housing 100) and sliding distally along the length of opening 120. As needle 10 continues its proximal movement, it no longer constrains it radially and ball 122 moves completely out of groove 75. When ball 122 is positioned such that edge 155 is above it, ball 122 will have traveled radially into lumen 93 as far as it can, constrained by the dimensions of opening 120 and partially occluding lumen 93.
If bevels 30 and 40 are not facing ball 122 or are partially facing ball 122, the device operates in a similar manner. That is to say, when needle tip 25 passes ball 122, needle 10 no longer constrains ball 122. Spring 110 urges ball 122 along opening 120 so that ball 122 moves out of groove 75 and pivots about edge 155. Ball 122 is constrained from entering lumen 93 by the dimensions and geometry of opening 120. Ball 122 thus partially occludes lumen 93.
The position of ball 122 in opening 120 and partially occluding lumen 93 is shown in
Movement of the shield assembly in the distal direction (such that shield assembly 90 slides off distal end 20 of the needle) is prevented by the interaction of area of enlarged cross section 14 on needle 10 and rear opening 140 of second housing 100. Movement of the shield assembly in the proximal direction (to expose needle tip 25) is prevented by distal end 20 of needle 10 abutting ball 122.
The distance from enlarged cross section 14 to tip 25 is set so that when tip 25 is aligned with ball 122, there is sufficient space for the ball to move beneath second housing 100 in opening 120. The angle formed by upper surface 136 tangential to ball 122 is as described above with reference to
After deployment, but before needle 10 moves distally, part of ball 122 lies in lumen 93 and part of it is urged against distal wall 157 of opening 120 by spring 110. The top of ball 122 lies beneath distal end 135 of second housing 100. In an alternative embodiment, spring 110, having expanded, closes off the top of opening 120. Ball 122 is thus radially and axially constrained in opening 120. If needle 10 moves distally, it will abut ball 122, which will be forced against distal wall 157 of second housing 100 and surface 136. Further distal movement of needle 10 and hence emergence of needle tip 25 from the shield assembly will be prevented.
Lumen 93 is sized such that needle 10 fits relatively snugly inside it. Thus, when needle 10 is moved distally (i.e. shield 90 is moved proximally) and ball 122 abuts needle tip 25, needle 10 will not move away from ball 122. Lumen 93 thus provides support opposite ball 122 to prevent needle 10 from wiggling, and to prevent tip 25 from moving such that it pierces first housing 95. The snugness of the fit between lumen 93 and needle 10 also facilitates the threading of shield 90 onto needle 10 (i.e. the distal end of shield 90 is threaded onto the proximal end of the needle). The snug fit means that the shield is guided so that proximal end 15 of needle 10 enters opening 140 in proximal end 130 of cap 100. This is important because opening 140 is typically only 0.001 inch larger than the diameter of needle 10.
In an alternative embodiment, ball 122 fully enters lumen 93. Ball 122 has a diameter slightly larger than that of lumen 93. Ball 122 is then axially constrained by lumen 93 and needle 10. In this case, lumen 93 is also dimensioned to provide support for needle 10 opposite ball 122, thus preventing wiggle of the needle and preventing tip 25 from piercing first housing 95.
In order to move out of groove 75 ball 122 moves a distance at least equal to the amount by which it protrudes from opening 150 plus the wall thickness of cap 100 (approx. 0.003″ to 0.005″). When the shield is deployed ball 122 extends into lumen 93 by an amount approximately equal to that distance. This leaves part of lumen 93 occluded. If a small gauge needle is used, a larger ball is needed in order to occlude lumen 93 sufficiently to prevent needle tip 25 from poking through the un-occluded part of lumen 93. If a large gauge needle is used, the ball can be smaller (i.e if the needle has a large diameter, the ball can be smaller).
The above description includes operation of needle shield 90 with catheter assembly 50, providing, in addition to a needle shielding function, a mechanism for locking shield 90 to catheter assembly 50 and unlocking it. This provides the added benefit of ensuring that shield 90 can never be removed from catheter hub 52 until needle tip 25 is shielded. In cases where a catheter lock is not needed, cap 100 can be closed (i.e. lack opening 120) and slightly enlarged to accommodate the entire diameter of ball 122.
The following is a description of a second type of catheter introducer assembly embodying the invention. In this second type of catheter introducer, when the needle is shielded, a tube covers the entire length of the needle and restrains the needle shield from further distal movement. Reference is made to
The body is pierced by needle 210, which has an outer surface 212, a proximal end 215, a distal end 220 and a lumen 222. Distal end 220 has a sharp point 225. Distal end is beveled, with two bevels—surfaces 230 and 240 forming a slope extending from the sharp point 225 in a proximal direction. More or less than two bevels may be used. Proximal end 215 is secured to needle hub 245.
Needle hub 245 has a tube 250 extending backwards from where it is secured to proximal end 215 of needle 210. Needle hub tube 250 has a proximal end 254 and a distal end 252 (to which needle 210 is secured). Needle hub tube 250 has lumen 260 which is coaxial with lumen 220 of needle 210 so that fluid can flow along lumen 222 and into lumen 260. Needle hub tube 250 is integral and coaxial with another tube 255 which forms a handle and has proximal end 258 and distal end 256. Tubes 250 and 255 are joined at the back 275 (proximal end) of the assembly. That is to say proximal end 254 of needle tube 250 and proximal end 258 of handle tube 255 are joined at back 275. Needle hub 250 is open at the back (has hole 270), which is fitted with a vent plug to permit air but not liquid to escape as fluid enters lumen 222 and flows into lumen 260. Both tubes 250 and 255 are transparent (or at least have a transparent part) so that the flow of fluid can be seen by the user. Tube 255 has an exterior circumferential flange 272 located at distal end 256, approximately in line with the area where proximal end 215 of needle 210 is secured to needle hub 245. Tube 255 also has an interior circumferential flange 274 substantially in line with exterior flange 272. The combination of needle hub tube 250 and handle tube 255 can be regarded as two concentric cylinders. Between tubes 250 and 255 is an annular space 276 which extends from distal end 256 to back 275.
Catheter assembly 280 has a catheter adapter or hub 282 having proximal end 285, distal end 288 and lumen 290 extending between the proximal and distal ends. Catheter tube 286 extends distally out of distal end 288. Needle 210 lies within lumen 290 of catheter assembly 280 prior to insertion into the body. Once needle 210 has been inserted into the patient, together with catheter tube 286 needle 210 is withdrawn by pulling it in a proximal direction. Catheter hub 282 has an inner surface 292 and an outer surface 291. Inner surface 292 is provided with a circumferential groove 293, the purpose of which has been explained above and will be explained in due course. A single depression, indentation, circumferential ridge or raised portion will serve the same purpose as the circumferential groove.
Needle shield assembly 2110 has a proximal end 2120, a distal end 2115 and a lumen 2112 extending from the proximal to the distal end. Lumen 2112 is dimensioned at distal end 2115 so that shield assembly 2110 can slide axially and rotate on needle 210. Shield assembly 2110 includes two parts—first housing 295 and cap 2100. Cap 2100 is at distal end 2115 and fits inside catheter hub 282. Shield 2110 is concentric with tubes 250 and 255. First housing 295 of shield 2110 lies at least partially in annular space 276 when the shield is in its non-deployed position. First housing 295 can slide back and forth in an axial direction in annular space 276. First housing 295 is also at least partially transparent to permit the user to see fluid flow. Proximal end 2120 of shield 2110 is provided with circumferential flange 2117. When shield 2110 moves in a distal direction axially along annular space 276, flange 2117 will eventually abut interior flange 274 of handle tube 255 and will be prevented from further distal movement. In the deployed position, proximal end 2121 abuts interior flange 274 at distal end 256 of handle tube 255.
First housing 295 has a distal end 297 with stepped area 2105—an area of reduced diameter which allows coil spring 2111 to be placed on first housing 295 and cap 2100 to be placed over it. Stepped area 2105 can be formed separately from first housing 295 and attached to it. Spring 2111 is a compression spring, which exerts a force axially in the proximal and distal directions. Towards distal end 297 of first housing 295, but still in the stepped area 2105, first housing is provided with an opening 2120, dimensioned to accommodate ball 2122.
Cap 2100 is a metal stamping having a proximal end 2130 and a distal end 2135. When first housing 295 and cap 2100 are assembled, second housing 2100 covers distal end 297 of the first housing and spring 2111. Cap 2100 is provided with opening 2150 which is dimensioned such that part of ball 2122 can protrude through it and into groove 293. Cap 2100 is dimensioned to fit in catheter hub 282. The part of first housing 295 immediately adjacent stepped area 2104 also fits in catheter hub 282.
When needle shield assembly 2110 is attached to catheter hub 282 (i.e. cap 2100 and part of first housing 295 are in catheter hub 282), prior to deployment, part of ball 2122 protrudes through opening 2150 and lies in groove 293. This locks needle shield assembly 2110 to catheter hub 282, while allowing catheter hub 282 to rotate relative to needle shield assembly 2110, depending on the extent of groove 293 (i.e. whether it is circumferential or permits only limited movement because it does not extend around the entire inner circumference of the catheter hub). Part of ball 2122 also lies in lumen 2112 of first shield assembly 2110 and abuts outer surface 212 of needle 210 (i.e. ball 2122 touches outer wall 212 of needle 210). Needle 210 and shield assembly 2110 can slide and rotate relative to each other with very low friction. Ball 2122 is radially constrained by groove 293 and needle 210. Needle shield assembly 2110 is thus locked into catheter hub 282. Spring 2111 exerts a force on ball 2122 axially, in the distal direction. Moreover, the presence of needle 10 abutting ball 2122 radially constrains ball 2122 and prevents it from moving out of groove 293. This is shown in
Once catheter tube 286 has been placed in the patient, needle 210 is pulled in a proximal direction (that is to say, as needle shield assembly 2110 moves towards tip 225 of needle 210 or needle hub 245 is pulled proximally). If bevels 230 and 240 are facing ball 2122, then, when first bevel 240 comes into alignment with ball 2122, ball 2122 is less radially constrained by needle and, urged by spring 2111, it begins to move in opening 2120, distally and radially. Ball 2122 thus moves out of opening 2150 in cap 2100 and groove 293 in catheter hub 282 and radially inwards further into lumen 2112 of shield assembly 2110, pivoting about edge 2155, (a wall of opening 2150 in cap 2100) and sliding distally along the length of opening 2120. When second bevel 230 is aligned with ball 2122, needle 210 no longer constrains it radially and it moves completely out of groove 293. When ball 2122 is positioned such that edge 2155 is above it, ball 2122 will have traveled radially into lumen 1212 as far as it can, constrained by the dimensions of opening 2120 and partially occluding lumen 2112.
If bevels 230 and 240 are not facing ball 2122 or are partially facing ball 2122, the device operates in a similar manner as described above. Spring 2111 urges ball 2122 along opening 2120 so that ball 2122 moves out of groove 293 and pivots about edge 2155. Ball 2122 is constrained from entering lumen 293 by the dimensions and geometry of opening 2120. Ball 2122 thus partially occludes lumen 2112.
After ball 2122 has moved to the point where it partially occludes lumen 2112 as described, flange 2117 of shield assembly 2110 abuts interior flange 274 of tube 255, and further pulling of needle 210 causes shield assembly 2110 to come out of catheter hub 282 due to the fact that ball 2122 is no longer in groove 293. The force of groove 293 against ball 2122 due to the pulling of the needle in a proximal direction may also urge ball 2122 radially into lumen 2112.
Movement of the shield assembly in the distal direction (such that shield assembly 2110 eventually slides off distal end 220 of the needle) is prevented by the interaction of flanges 274 and 2117. Movement of the shield assembly in the proximal direction (to expose needle tip 225) is prevented by distal end 220 of needle 210 abutting ball 2122 which abuts wall 2157 of first housing 295 and upper inner wall 2136 of second housing or cap 2100.
The distance from flange 2117 to needle tip 225 is set so that when tip 225 is aligned with ball 2122, there is sufficient space for the ball to move beneath cap 2100 in opening 2120. The considerations for angles α and β (i.e. the tangent formed between ball 2122 and surface 2136 and the smallest bevel angle) are as set forth above in relation to
After deployment, but before needle 210 moves distally, part of ball 2122 lies in lumen 2112 and part of it is urged against distal wall 2157 of opening 2120 by spring 2111. The top of ball 2122 lies beneath upper surface 2136 of distal end 2135 of cap 2100. Distal end 299 of first housing 295 and cap 2100 are likewise dimensioned to overhang so that tip 225 can never emerge from distal end 2115. Multiple balls can likewise be used. The foregoing design also provides a catheter locking feature as previously described.
Once the shield has been deployed, but before needle 210 moves distally, part of ball 2122 lies in lumen 2112 and part of it is urged against wall 2157 of opening 2120 by spring 2111. The top of ball 2122 lies beneath upper surface 2136 of distal end 2135 of cap 2100. Opening 2120 may be closed off by spring 2111. Ball 2122 is radially and axially constrained in opening 2120. If needle 210 moves distally, it will abut ball 2122, which will be forced against distal wall 2157 of first housing 295 and wall 2136 of cap 2100. Needle 210 thus cannot emerge distally from the shield.
Lumen 2112 provides anti-wiggle support for needle 210 as described above in relation to an earlier embodiment. Similar considerations as described above apply to movement of the ball and the dimensions of the ball relative to the needle gauge size. That is to say, larger balls are used for smaller gauge sizes and vice versa.
First housing 295 and the tube part of shield 2110 can be made out of an extruded polymeric tube 950 as shown in
The following is a description of a catheter introducer assembly embodying the invention, in which distal movement of the needle shield is restrained by a tether secured to the needle hub. Reference is made to
Needle hub 50 is open at the back (has hole 70), which may be fitted with a vent plug to permit air but not liquid to escape as fluid enters lumen 22 and flows into lumen 60. Tube 50 is transparent (or at least has a transparent part) so that the flow of fluid can be seen by the user. Tube 50 has an exterior circumferential flange 72 located at distal end 52, approximately in line with the area where proximal end 15 of needle 10 is secured to needle hub 45.
Circumferential flange 72 is provided with a small opening 74, through which is threaded tether 75. Tether 75 has a proximal end 77 and a distal end 76. Proximal end is T-shaped. Arm 79 of the T prevents tether 75 from escaping through opening 74 when tether 75 moves distally. Distal end 76 is secured to needle shield assembly 110 (described below). Tether 75 thus prevents needle shield assembly from moving off tip 25 of needle 10 in the distal direction. Tether 75 can be made of nylon and closely resembles a label holder used in the retail industry to secure labels to items of clothing. Tether 75 may be integrally molded with first housing 95 but does not have to be.
Catheter assembly 80 has a catheter hub 82 having proximal end 85, distal end 88 and lumen 90 extending between the proximal and distal ends. Catheter tube 86 extends distally out of distal end 88. Needle 10 lies within lumen 90 of catheter assembly 80 prior to insertion into the body. Once needle 10 has been inserted into the patient, together with catheter tube 86, needle 10 is withdrawn by pulling it in a proximal direction. Catheter hub 82 has an inner surface 92 and an outer surface 91. Inner surface 92 is provided with a circumferential groove 93, the purpose of which will be explained in due course. A single depression, indentation, circumferential ridge or raised portion will serve the same purpose as the circumferential groove.
Needle shield assembly 110 has a proximal end 118, a distal end 115 and a lumen 112 extending from the proximal to the distal end. Lumen 112 is dimensioned so that shield assembly 110 can slide axially and rotate on needle 10. Shield assembly 110 is contained in mating parts—first housing 95 and cap 100. Cap 100 is at distal end 115 and fits inside catheter assembly 80.
First housing 95 has a distal end 97 with stepped area 105—an area of reduced diameter which allows coil spring 111 to be placed on first housing 95 and cap 100 to be placed over it. Spring 111 is a compression spring, which exerts a force axially in the proximal and distal directions. Towards distal end 97 of first housing 95, but still in the stepped area 105, first housing is provided with an opening 120, dimensioned to accommodate ball 122.
Cap 100 is a metal stamping having a proximal end 130 and a distal end 135. Cap 100 covers distal end 97 of the first housing and spring 111. Cap 100 is provided with opening 150 which is dimensioned such that part of ball 122 can protrude through it and into groove 93. Cap 100 is dimensioned to fit in catheter hub 82. The part of first housing 95 immediately adjacent stepped area 104 also fits in catheter hub 82.
When needle shield assembly 110 is attached to catheter hub 82 (i.e. cap 100 and part of first housing 95 are in catheter hub 82), prior to deployment, part of ball 122 protrudes through opening 150 and lies in groove 93. This locks needle shield assembly 110 to catheter hub 82, while allowing catheter hub 82 to rotate relative to needle shield assembly 110, depending on the extent of groove 93 (i.e. whether it is circumferential or permits only limited movement because it does not extend around the entire inner circumference of the catheter hub). Part of ball 122 also lies in lumen 112 of first shield assembly 110 and abuts outer surface 12 of needle 10 (i.e. ball 122 touches outer wall 12 of needle 10). Needle 10 and shield assembly 110 can slide and rotate relative to each other with very low friction. Ball 122 is radially constrained by groove 93 and needle 10. Spring 111 exerts a force on ball 122 axially, in the distal direction. Moreover, the presence of needle 10 abutting ball 122 radially constrains ball 122 and prevents it from moving out of groove 93.
Once catheter tube 86 has been placed in the patient, needle 10 is pulled in a proximal direction (that is to say, as needle shield assembly 110 moves towards tip 25 of needle 10 or needle hub 45 is pulled proximally). If bevels 30 and 40 are facing ball 122, then, when first 20 bevel 40 comes into alignment with ball 122, ball 122 is less radially constrained by needle 10 and, urged by spring 111, it begins to move in opening 120, distally and radially. Ball 122 thus moves out of opening 150 in cap 100 and groove 93 in catheter hub 82 and radially inwards further into lumen 112 of shield assembly 110, pivoting about edge 155, (distal wall of opening 150 in cap 100) and sliding distally along the length of opening 120. When second bevel 30 is aligned with ball 122, needle 10 no longer constrains it radially and it moves completely out of groove 93. When ball 122 is positioned such that edge 155 is above it, ball 122 will have traveled radially into lumen 112 as far as it can, constrained by the dimensions of opening 120 and partially occluding lumen 112. This is shown in
As needle hub 45 moves proximally, tether 75 plays out through opening 74, such that arm 79 moves distally. When ball 122 has moved to the point where it partially occludes lumen 112 as described, arm 79 of tether 75 abuts flange 72, and further pulling of needle 10 causes shield assembly 110 to come out of catheter hub 82 due to the fact that ball 122 is no longer in groove 93. The force of groove 93 against ball 122 due to the pulling of the needle in a proximal direction may also urge ball 122 radially into lumen 112.
Movement of the shield assembly in the distal direction (such that shield assembly 110 eventually slides off the distal end of the needle) is prevented by the interaction of arm 79 and flange 72. Movement of the shield assembly in the proximal direction (to expose needle tip 25) is prevented by distal end 20 of needle 10 abutting ball 122 which abuts wall 157 of opening 120.
The distance from tether arm 79 to needle tip 25 is set so that when tip 25 is aligned with ball 122, there is sufficient space for the ball to move beneath cap 100 in opening 120. The relationship between α (the tangential angle between ball 122 and upper surface 136 of distal end 135 of cap 100) and β (the smallest needle bevel angle) is described above, as are the considerations of the support provided by lumen 112 opposite ball 122 to prevent needle 10 from wiggling, and to prevent tip 25 from moving such that it pierces first housing 95. The relationship between ball and needle gauge size is also as described above.
As shown in
The following is a description of the application of the needle shield to a hypodermic syringe (a needle-based device without a catheter threaded onto it). Reference is made to
Needle shield assembly 900 is made up of two mating parts—first housing 905 and second housing or cap 910. First housing 905 has a proximal end 909 and a distal end 907. Extending between the proximal and distal ends is lumen 913, which is dimensioned so that first housing 905 can slide axially on needle 10. Extending from proximal end 909 towards distal end 907 is stepped area 915. This is an area of reduced diameter which allows coil spring 911 to be placed on first housing 905. Spring 911 is a compression spring, which exerts a force axially in the proximal and distal directions. Towards distal end 907 of first housing 905, but still in the stepped area 915, first housing is provided with an opening 920, dimensioned to accommodate ball 922.
Second housing or cap 910 has a proximal end 930 and a distal end 935. Proximal end 930 is provided with opening 937 which is dimensioned such that it is slightly larger than the diameter of needle 510. Thus, second housing 910 can slide axially along the needle from proximal end 505 towards distal end 525. When first and second housings 905 and 910 are assembled, second housing 910 covers most of first housing 905, except for the proximal end. Second housing thus covers spring 911. Second housing 910 is provided with opening 940 which is dimensioned such that part of ball 922 can protrude through it. This makes needle shield assembly 900 very compact. However, second housing 910 can me made slightly larger or provided with a blister to accommodate ball 922, so that ball 922 is completely covered.
When needle shield assembly is at needle hub 512, prior to deployment, part of ball 922 protrudes through opening 940. Part of ball 922 also lies in lumen 913 of first housing 905 and abuts outer surface 522 of needle 510 (i.e. ball 922 touches outer wall 522 of needle 510). Shield assembly 900 can slide from this position along needle 510 in a distal direction with very low friction. Ball 922 is radially constrained by the diameter of opening 940, which is sized so that ball 922 cannot escape through opening 940 and out of shield 900. Ball 922 is also radially constrained by needle 510 in the other direction. Spring 911 exerts a force 5 on ball 922 axially, in the distal direction.
Tether or strap 800 is attached to proximal end 909 of first housing 905. It is preferably made in the same molding as first housing 905 but need not be. Tether 800 has distal end 802 (attached to proximal end 909 of first housing 905) and proximal end 804 which extends back and outwards from shield 900. At proximal end 804 is handle 806, which can be grasped by a user. This is molded with strap 800 but can be a separate piece attached to strap 800. Tether or strap 800 is made of a flexible, semi-rigid material such as nylon. Any material that bends but provides some longitudinal compressive strength will be suitable as long as it allows force to be imparted to shield 900 via tether 800.
Needle hub 512 is provided with integrally molded with restraint 514. Restraint 514 has a track 516 along which tether 800 can slide in a distal direction as needle shield 900 slides distally along needle 510. Restraint 514 has stop 518 which prevents further travel of tether 800 when handle 806 reaches stop 518. Restraint 514 has an open channel 520 which allows tether 800 to be placed in track 516 during manufacture but which prevents tether 800 from being easily removed.
Once needle 510 has been used and is to be shielded, the user simply grasps handle 806 and pushes it so that needle shield 900 slides distally along needle 510. When needle shield 900 reaches a point where needle tip 525 passes ball 922, ball 922 is less radially constrained by needle 510 and, urged by spring 911, it begins to move in opening 920, distally and radially. Ball 922 thus moves out of opening 940 and radially inwards further into lumen 913 of shield assembly 900, pivoting about edge 955, which is a wall of opening 940 in second housing 910. When needle tip 525 passes ball 922, needle 510 no longer constrains ball 922. Spring 911 urges ball 922 along opening 920 so that ball 922 pivots about edge 955. Ball 922 is constrained from entering lumen 913 of first housing 905 by the dimensions and geometry of opening 920. Ball 922 thus partially occludes lumen 913.
When ball 922 has moved to a point where it partially occludes lumen 913, handle 806 has reached stop 518, preventing further pushing of handle 806 and hence tether 800. Movement of shield assembly 900 in the distal direction (such that shield assembly 900 slides off distal end 525 of the needle) is prevented by the abutment of stop 518 and handle 806. Movement of the shield assembly in the proximal direction (to expose needle tip 525) is prevented by distal end 525 of needle 510 abutting ball 922.
The length of tether 800 (to tip 525) relative to the length of first housing 905 is set so that when tip 525 is aligned with ball 922, there is sufficient space for the ball to move at least partially into lumen 913. Similar considerations described above in the context of a catheter inserter apply when selecting the angle formed between ball 922 and the part of needle shield 900 that is immediately radially outward of ball 922 and which ball 922 abuts when the shield is deployed. Proximal end 909 of first housing 905 is dimensioned to overhang so that tip 525 can never emerge from distal end 907.
When shield 900 is deployed, part of ball 922 lies in lumen 913 and part of it lies beneath distal end 935 of second housing 910, which radially constrains it. If shield assembly 900 is moved proximally, ball 922 will abut needle tip 525 and be forced against the distal and upper inside walls of second housing 910. Further proximal movement of the shield assembly and hence emergence of needle tip 25 will be prevented.
Lumen 913 is sized such that needle 510 fits relatively snugly in lumen 913. Thus, when needle shield 900 is moved proximally into deployment and ball 922 abuts needle tip 525, needle 510 will not move away from ball 922. Lumen 913 thus provides support opposite ball 922 to prevent needle 510 from wiggling, and to prevent tip 525 from moving such that it pierces first housing 905.
In an alternative embodiment, ball 922 fully enters lumen 913. Ball 922 has a diameter slightly larger than that of lumen 913. In this case, lumen 913 is also dimensioned to provide support for needle 910 opposite ball 922, thus preventing wiggle of the needle and preventing tip 525 from piercing first housing 905.
Application of the invention to a winged needle is shown in
Another winged needle application is shown in
The invention is shown in the context of a another winged needle (with or without catheter) in
When the ball has moved into its shielding position as described above, preventing proximal movement of shield assembly 8110, protrusion 810 of wing 804 abuts protrusion 812 of wing 802, preventing distal movement of wing 804 and hence of shield assembly 8110.
The invention in the context of a Huber needle is shown in
A blood collection device incorporating the shield shown in
While a sphere is the preferred choice for ball 122, a perfectly spherical object is not essential. In the embodiment of
In
Ball 122 can be enclosed within cap 100 as shown in
In the embodiment in
In the embodiment of
Although limited embodiments of the needle shield assemblies, their components, and their applications on different needle devices have been specifically described and illustrated, the descriptions are not intended to limit the scope of the basic invention. Many modifications and variations will be apparent to those skilled in the art. Accordingly, it is to be understood that the needle shield assemblies and their components constructed according to principles of this invention may be embodied other than as specifically described herein. The invention is also defined in the following claims.
This patent application claims priority from, and expressly incorporates by reference, the following provisional patent applications: 60/659,226—Shielding Apparatus for Locking onto a Needle—filed on Mar. 7, 2005;60/659,217—Needle Shielding Apparatus with Tubular Needle Cover—filed on Mar. 7, 2005;60/659,213—Needle Shielding Apparatus with Tether to Needle Hub—filed on Mar. 7, 2005;60/714,954—Blood Collection Device with Needle Shield—filed on Sep. 7, 2005.
Filing Document | Filing Date | Country | Kind | 371c Date |
---|---|---|---|---|
PCT/US2006/007909 | 3/6/2006 | WO | 00 | 9/6/2007 |
Publishing Document | Publishing Date | Country | Kind |
---|---|---|---|
WO2006/096633 | 9/14/2006 | WO | A |
Number | Name | Date | Kind |
---|---|---|---|
2798487 | Ferguson | Jul 1957 | A |
3459183 | Ring et al. | Aug 1969 | A |
4588398 | Daugherty et al. | May 1986 | A |
4596563 | Pande | Jun 1986 | A |
4755170 | Golden | Jul 1988 | A |
4762516 | Luther et al. | Aug 1988 | A |
4778453 | Lopez | Oct 1988 | A |
4790828 | Dombrowski et al. | Dec 1988 | A |
4832696 | Luther et al. | May 1989 | A |
4834718 | McDonald | May 1989 | A |
4846809 | Sims | Jul 1989 | A |
4863436 | Glick | Sep 1989 | A |
4887998 | Martin et al. | Dec 1989 | A |
4927414 | Kulli | May 1990 | A |
4929241 | Kulli | May 1990 | A |
4931048 | Lopez | Jun 1990 | A |
4944725 | McDonald | Jul 1990 | A |
4952207 | Lemieux | Aug 1990 | A |
4978344 | Dombrowski et al. | Dec 1990 | A |
5049136 | Johnson | Sep 1991 | A |
5059180 | McLees | Oct 1991 | A |
5116326 | Schmidt | May 1992 | A |
5120320 | Fayngold | Jun 1992 | A |
5160325 | Nichols et al. | Nov 1992 | A |
5215528 | Purdy et al. | Jun 1993 | A |
RE34416 | Lemieux | Oct 1993 | E |
5261895 | Kablik | Nov 1993 | A |
5300045 | Plassche, Jr. | Apr 1994 | A |
5304151 | Kuracina | Apr 1994 | A |
5322517 | Sircom et al. | Jun 1994 | A |
5328482 | Sircom et al. | Jul 1994 | A |
5334158 | McLees | Aug 1994 | A |
5344408 | Partika | Sep 1994 | A |
5360408 | Vaillancourt | Nov 1994 | A |
5360497 | Schneider et al. | Nov 1994 | A |
5376075 | Haughton et al. | Dec 1994 | A |
5429611 | Rait | Jul 1995 | A |
5447501 | Karlsson et al. | Sep 1995 | A |
5458658 | Sircom | Oct 1995 | A |
5466223 | Bressler et al. | Nov 1995 | A |
5558651 | Crawford et al. | Sep 1996 | A |
5582597 | Brimhall et al. | Dec 1996 | A |
5584809 | Gaba | Dec 1996 | A |
5599310 | Bogert | Feb 1997 | A |
5601536 | Crawford et al. | Feb 1997 | A |
5611781 | Sircom et al. | Mar 1997 | A |
5662610 | Sircom | Sep 1997 | A |
5669927 | Boebel et al. | Sep 1997 | A |
5683365 | Brown et al. | Nov 1997 | A |
5690619 | Erskine | Nov 1997 | A |
5697907 | Gaba | Dec 1997 | A |
5700250 | Erskine | Dec 1997 | A |
5718688 | Wozencroft | Feb 1998 | A |
5755699 | Blecher et al. | May 1998 | A |
5795339 | Erskine | Aug 1998 | A |
5853393 | Bogert | Dec 1998 | A |
5879337 | Kuracina et al. | Mar 1999 | A |
5951515 | Osterlind | Sep 1999 | A |
5951525 | Thorne et al. | Sep 1999 | A |
6001080 | Kuracina et al. | Dec 1999 | A |
6004294 | Brimhall et al. | Dec 1999 | A |
6117108 | Woehr et al. | Sep 2000 | A |
6210371 | Shaw | Apr 2001 | B1 |
6221047 | Greene et al. | Apr 2001 | B1 |
6379333 | Brimhall et al. | Apr 2002 | B1 |
6443929 | Kuracina | Sep 2002 | B1 |
6595955 | Ferguson et al. | Jul 2003 | B2 |
6629959 | Kuracina et al. | Oct 2003 | B2 |
6659984 | Crawford et al. | Dec 2003 | B2 |
6689102 | Greene | Feb 2004 | B2 |
6695814 | Greene et al. | Feb 2004 | B2 |
6743186 | Crawford et al. | Jun 2004 | B2 |
6749588 | Howell et al. | Jun 2004 | B1 |
6761706 | Vaillancourt | Jul 2004 | B2 |
6786891 | Hiejima | Sep 2004 | B2 |
6860871 | Kuracina et al. | Mar 2005 | B2 |
6881202 | Coleman et al. | Apr 2005 | B2 |
6976976 | Doyle | Dec 2005 | B2 |
RE38996 | Crawford et al. | Feb 2006 | E |
6997902 | Thorne et al. | Feb 2006 | B2 |
7125397 | Woehr et al. | Oct 2006 | B2 |
7144387 | Millerd | Dec 2006 | B2 |
7264613 | Woehr et al. | Sep 2007 | B2 |
7303548 | Rhad et al. | Dec 2007 | B2 |
7322963 | Goh | Jan 2008 | B2 |
7387616 | Li | Jun 2008 | B2 |
7611499 | Woehr et al. | Nov 2009 | B2 |
7811261 | Rubinstein et al. | Oct 2010 | B2 |
7927314 | Kuracina et al. | Apr 2011 | B2 |
7935080 | Howell et al. | May 2011 | B2 |
7959613 | Rhad et al. | Jun 2011 | B2 |
8100858 | Woehr et al. | Jan 2012 | B2 |
8235945 | Baid | Aug 2012 | B2 |
8251950 | Albert et al. | Aug 2012 | B2 |
8545454 | Kuracina et al. | Oct 2013 | B2 |
8556853 | Vaillancourt et al. | Oct 2013 | B2 |
20010047156 | Parker | Nov 2001 | A1 |
20020111566 | Crawford et al. | Aug 2002 | A1 |
20030036731 | Wilkinson et al. | Feb 2003 | A1 |
20030105431 | Howell | Jun 2003 | A1 |
20030216687 | Hwang | Nov 2003 | A1 |
20030220587 | Swenson | Nov 2003 | A1 |
20040049155 | Schramm | Mar 2004 | A1 |
20040049163 | Murashita | Mar 2004 | A1 |
20040167385 | Rioux et al. | Aug 2004 | A1 |
20040225262 | Fathallah et al. | Nov 2004 | A1 |
20050015054 | Chen | Jan 2005 | A1 |
20050119627 | Crawford | Jun 2005 | A1 |
20070100297 | Woehr et al. | May 2007 | A1 |
20080171986 | Baid | Jul 2008 | A1 |
20090131876 | Coyne | May 2009 | A1 |
20100016804 | Muskatello et al. | Jan 2010 | A1 |
20100191188 | Harding et al. | Jul 2010 | A1 |
20100191189 | Harding et al. | Jul 2010 | A1 |
20100249707 | Woehr et al. | Sep 2010 | A1 |
Number | Date | Country |
---|---|---|
1145813 | Mar 1997 | CN |
1547493 | Nov 2004 | CN |
3808353 | Aug 1989 | DE |
0443735 | Aug 1991 | EP |
0747085 | Dec 1996 | EP |
0749761 | Dec 1996 | EP |
0750916 | Jan 1997 | EP |
0826388 | Mar 1998 | EP |
0995459 | Apr 2000 | EP |
1291035 | Mar 2003 | EP |
1369142 | Aug 2005 | EP |
2016964 | Jan 2009 | EP |
2075029 | Jul 2009 | EP |
2767480 | Feb 1999 | FR |
H04102462 | Apr 1992 | JP |
2002330946 | Nov 2002 | JP |
2002539897 | Nov 2002 | JP |
9211885 | Jul 1992 | WO |
0057940 | Oct 2000 | WO |
0156642 | Aug 2001 | WO |
03011381 | Feb 2003 | WO |
2004043521 | May 2004 | WO |
2006096634 | Sep 2006 | WO |
2006096635 | Sep 2006 | WO |
2006096636 | Sep 2006 | WO |
2007022373 | Feb 2007 | WO |
2010101573 | Sep 2010 | WO |
2010110789 | Sep 2010 | WO |
2012075402 | Jun 2012 | WO |
2012075421 | Jun 2012 | WO |
Entry |
---|
Erskine, Canadian Application No. 2,599,943, Office Action dated Dec. 30, 2010, 2 pages. |
Erskine, Canadian Application No. 2,599,945, Notice of Allowance dated Nov. 15, 2010, 1 pages. |
Erskine, Canadian Application No. 2,599,955, Office Action dated Dec. 21, 2010, 3 pages. |
Erskine, Canadian Application No. 2,599,938, Office Action dated Dec. 20, 2010, 2 pages. |
Erskine, Japanese Application No. P2008-500805, Final Office Action dated Jan. 25, 2011, 25 pages. |
Erskine, Japanese Application No. P2008-500804, Notice to Grant dated Feb. 2, 2011, 6 pages. |
Erskine, Office Communication for Application No. 11/817,687 dated Dec. 9, 2010, 19 pages. |
Erskine, Mexican Application No. MX/a/2007/010944, Office Action dated Mar. 11, 2011, 4 pages. |
European Patent Application No. EP06737125, Search Report dated Feb. 10, 2010. |
Erskine, Australian IP Examination Report No. 2 dated Feb. 25, 2010, Reference No. 30355386/MRF/TLG/tzs, Application No. 2006220690, 2 pages. |
Erskine, Canadian Application No. 2,599,943, Office Action dated Nov. 20, 2009, 2 pages. |
Erskine, Chinese Application No. 200680007590, Office Action dated Aug. 21, 2010, 4 pages. |
Erskine, Australian Application No. 2006220691, Notice of Acceptance dated Jun. 9, 2010, 2 pages. |
Erskine, Canadian Application No. 2,599,945, Office Action dated Nov. 13, 2009, 2 pages. |
Erskine, Chinese Application No. 200680007484, Notification to Grant Patent Right dated Jun. 11, 2010, 4 pages. |
Patent Cooperation Treaty, PCT/US06/07911, PCT International Search Report and Written Opinion, dated Jun. 23, 2006, 8 pages. |
Patent Cooperation Treaty, PCT/US06/07911, PCT International Preliminary Report on Patentability, dated Feb. 12, 2007, 4 pages. |
Erskine, U.S. Appl. No. 11/817,891, Office Communication dated Jun. 11, 2010, 11 pages. |
Erskine, Australian Application No. 2006220692, Examiners First Report on Patent Application dated Oct. 21, 2008, 2 pages. |
Erskine, Canadian Application No. 2,599,955, Office Action dated Mar. 5, 2010, 2 pages. |
Erskine, Chinese Application No. 200680007485.0, Office Action dated Jun. 19, 2009, 6 pages. |
Erskine, Chinese Application No. 200680007485.0, Notification to Grant Patent Right dated Jun. 4, 2010, 5 pages. |
Erskine, Japanese Application No. P2008-500805, Office Action dated Apr. 20, 2010, 4 pages. |
Erskine, Malaysia Application No. PI 20071465, Substantive Examination Report dated Apr. 30, 2010, 3 pages. |
Patent Cooperation Treaty, PCT/US06/07912, PCT International Preliminary Report on Patentability, dated Sep. 20, 2007, 5 pages. |
Patent Cooperation Treaty, PCT/US06/07912, PCT International Search Report and Written Opinion, dated Jun. 26, 2006, 8 pages. |
Erskine, Taiwanese Application No. 095107584, Decision to Grant Patent dated Mar. 4, 2009, 5 pages. |
Erskine, U.S. Appl. No. 11/817,687, Office Communication dated Jun. 30, 2010, 8 pages. |
Erskine, U.S. Appl. No. 11/817,687, Office Communication dated Jan. 21, 2010, 9 pages. |
Erskine, Australian Application No. 2006220689, Examiners First Report on Patent Application dated Jan. 15, 2009, 3 pages. |
Erskine, Australian Application No. 2006220689, Patent Granted dated Jun. 18, 2010, 3 pages. |
Erskine, Canadian Application No. 2,599,938, Office Action dated Feb. 23, 2010, 2 pages. |
Erskine, Chinese Application No. 20068007548.2, Office Action dated Sep. 4, 2009, 4 pages. |
Erskine, Chinese Application No. 200680007548.2, Notification to Grant Patent Right dated Jun. 12, 2010, 4 pages. |
Erskine, Australian Application No. 2006220690, Notice of Acceptance dated Jun. 15, 2010, 3 pages. |
Erskine, Japanese Application No. P2008-500802, Office Action dated Jun. 29, 2010, 6 pages. |
Erskine, Malaysia Application No. PI 20071468, Substantive Examination Report dated Apr. 16, 2010, 2 pages. |
Patent Cooperation Treaty, PCT/US06/07910, PCT International Preliminary Report on Patentability, dated Jul. 3, 2007, 20 pages. |
Patent Cooperation Treaty, PCT/US06/07909, PCT International Search Report and Written Opinion, dated Jun. 26, 2006, 8 pages. |
Erskine, Taiwanese Application No. 095107593, Decision to Grant Patent dated Dec. 11, 2009, 5 pages. |
Patent Cooperation Treaty, PCT/US09/036197, PCT International Search Report and Written Opinion dated Apr. 28, 2009, 14 pages. |
Patent Cooperation Treaty, PCT/US09/038246, PCT International Search Report and Written Opinion dated May 20, 2009, 11 pages. |
Erskine, U.S. Appl. No. 11/817,891, Office Communication dated Oct. 19, 2009, 10 pages. |
Erskine, Australian Application No. 2006220690, Examiner's First Report on Patent dated Nov. 11, 2008, 3 pages. |
Erskine, Chinese Application No. 200680007590, Office Action dated May 21, 2009, 11 pages. |
Erskine, European Application No. EP06737126, Supplementary European Search Report dated Feb. 11, 2010, 4 pages. |
Patent Cooperation Treaty, PCT/US06/07910, PCT International Search Report and Written Opinion, dated Jul. 5, 2006, 8 pages. |
Erskine, Taiwanese Application No. 095107587, Office Action dated Oct. 12, 2009, 12 pages. |
Erskine, Australian Application No. 2006220691, Examiner's First Report on Patent dated Sep. 19, 2009, 2 pages. |
Erskine, Chinese Application No. 200680007484, Office Action dated Aug. 21, 2009, 13 pages. |
Erskine, Taiwanese Application No. 095107585, Office Action dated Apr. 6, 2009, 9 pages. |
Erskine, Taiwanese Application No. 095107585, Office Action dated Oct. 15, 2009, 7 pages. |
Osinski, U.S. Appl. No. 11/817,687, Notice of Allowance & Fees Due, Jun. 30, 2011, 8 pages. |
Erskine, Japanese Application No. JP07-5616-XY, Decision to Grant a Patent, dated Apr. 5, 2011, 6 pages. |
Erskine, Taiwan Application No. 095107585, Office Action, dated Mar. 17, 2011, 3 pages. |
Erskine, Mexian Application No. MX/a/2007/010946, Office Action, dated Apr. 2011, 2 pages. |
Erskine, Japan Application No. P2008-500802, Notice of Reasons for Rejection, dated Apr. 5, 2011, 4 pages. |
Erskine, China Application No. 201010109122.6, Office Action, dated Apr. 1, 2011, 11 pages. |
Price, Office Action Communication for U.S. Appl. No. 11/817,890 dated Aug. 31, 2011, 33 pages. |
Patent Cooperation Treaty, International Preliminary Report on Patentability and Written Opinion of the International Searching Authority for PCT/US2009/038246 dated Oct. 6, 2011, 7 pages. |
Patent Cooperation Treaty, International Preliminary Report on Patentability and Written Opinion of the International Searching Authority for PCT/US2009/036197 dated Sep. 15, 2011, 10 pages. |
Patent Cooperation Treaty, Notification of Transmittal of the International Search Report and the Written Opinion of the International Searching Authority, or the Declaration for PCT/US2011/063118 dated Apr. 3, 2012, 17 pages. |
Patent Cooperation Treaty, Notification of Transmittal of the International Search Report and the Written Opinion of the International Searching Authority, or the Declaration for PCT/US2011/063081 dated Mar. 22, 2012, 10 pages. |
Desanto, Office Action Communication for U.S. Appl. No. 11/817,890 dated Apr. 30, 2012, 14 pages. |
Shamsudin, Substantive/Modified Substantive Examination and Search Report, Application No. PI 20071467, Mar. 15, 2013, 4 pages. |
Ehrsam, Supplementary European Search Report, Application No. EP 09 84 1250, Feb. 26, 2013, 5 pages. |
Omgba, Office Action Correspondence, U.S. Appl. No. 13/114,589, Apr. 10, 2013, 15 pages. |
Patent Cooperation Treaty, Notification of Transmittal of the International Search Report and the Written Opinion of the International Searching Authority, or the Declaration for PCT/US12/32578 dated Aug. 3, 2012, 26 pages. |
European Patent Office, European Search Report for EP12169737 dated Jul. 25, 2012, 4 pages. |
European Patent Office, European Search Report for EP12169713 dated Jul. 26, 2012, 5 pages. |
Price, U.S. Appl. No. 11/817,891, Non-Final Office Action, Sep. 16, 2014, 94 pgs. |
European Patent Office, Supplementary European Search Report for EP09842422 dated Aug. 27, 2012, 7 pages. |
Desanto, Office Action Communication for U.S. Appl. No. 11/817,890 dated Oct. 11, 2012, 26 pages. |
Desanto, Notice of Allowance and Fee(s) Due for U.S. Appl. No. 11/817,890 dated Sep. 17, 2013, 17 pages. |
Matney, Office Action Communication for U.S. Appl. No. 13/254,163 dated Oct. 15, 2013, 81 pages. |
Omgba, Office Action Communication for U.S. Appl. No. 13/144,589 dated Oct. 31, 2013, 19 pages. |
Patent Cooperation Treaty, Preliminary Report on Patentability and Written Opinion of the International Searching Authority for PCT/US2012/032578 dated Oct. 8, 2013, 10 pages. |
European Patent Office, Intention to Grant for EP Application No. 06 737 126.0 dated Jun. 17, 2013, 92 pages. |
Canadian Patent Office, Notice of Allowance for CA Application No. 2,599,943 dated Jul. 3, 2013, 1 page. |
Desanto, Office Action Communication for U.S. Appl. No. 11/817,890 dated Jun. 6, 2013, 19 pages. |
Patent Cooperation Treaty, International Preliminary Report on Patentability for PCT/US20111063081 dated Jun. 4, 2013, 7 pages. |
Patent Cooperation Treaty, International Preliminary Report on Patentability for PCT/US2011/063118 dated Jun. 4, 2013, 8 pages. |
Omgba, Office Action Communication for U.S. Appl. No. 13/114,589 dated Sep. 14, 2012, 39 pages. |
Flick: U.S. Appl. No. 13/259,715 filed Dec. 2, 2011, Office Action Dec. 17, 2012, 42pgs. |
State Intellectual Property Office of the the People's Republic of China, Notification of the First Office Action for Application No. CN 201180066317 dated Oct. 27, 2014, 19 pages. |
Number | Date | Country | |
---|---|---|---|
20090249605 A1 | Oct 2009 | US |
Number | Date | Country | |
---|---|---|---|
60659213 | Mar 2005 | US | |
60659217 | Mar 2005 | US | |
60659226 | Mar 2005 | US | |
60714954 | Sep 2005 | US |